Abacavir + Dolutegravir + Lamivudine
Formulations: - Oral > Solid > tablet: 60 mg (as sulfate) + 5 mg + 30 mg (dispersible, scored) Indications: - Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified Source: EML workbook import
